(2026). Intergenic trans-splicing–driven formation of a chimeric FAM168B: :ANKRD42 transcript in prostate cancer. 3 Biotech.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Intergenic Trans-splicing–driven Formation of a Chimeric FAM168B: :ANKRD42 Transcript in Prostate Cancer."
3 Biotech 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Intergenic Trans-splicing–driven Formation of a Chimeric FAM168B: :ANKRD42 Transcript in Prostate Cancer."
3 Biotech, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.